Who owns Cardium Therapeutics?

Key details on Cardium Therapeutics (Ticker: CXM)

Who owns Cardium Therapeutics?

Is CXM a good stock to own? Find out who bought Cardium Therapeutics, who sold Cardium Therapeutics (CXM) stock, and who holds a large position in Cardium Therapeutics.

Fund Name Number of Shares Share Valuation As Of
Vanguard 1.73M $121175 June 30, 2013
Creative Planning 293223 $20525 June 30, 2013
Geode Capital Management 291383 $20396 June 30, 2013
CalPERS 291000 $69840 June 30, 2012
UBS AG 67791 $4745 June 30, 2013
NORTHERN TRUST 62024 $0 June 30, 2013
Guggenheim Capital, LLC Managers 59045 $4133 June 30, 2013
CITADEL ADVISORS 58485 $4093 June 30, 2013
Knight Capital 44402 $7104 March 31, 2013
National Asset Management 41384 $7035 March 31, 2013
STATE STREET CORPORATION 38600 $6176 March 31, 2013
Lyons Wealth Management 34130 $2047 June 30, 2013
Aperio 16667 $1000 June 30, 2013
Shufro Rose & Co 12500 $0 June 30, 2013
Renaissance Technologies 11193 $3022 March 31, 2012
Financial Architects 11000 $990 June 30, 2013
Credit Suisse AG 10400 $1976 Sept. 30, 2012
Bank of America Corporation 6925 $0 Dec. 31, 2012
Barclays 3083 $986 Sept. 30, 2012
Nollenberger Capital Partners 3000 $1680 Sept. 30, 2010
Vantage Investment Advisors 1350 $999 Dec. 31, 2013

Who sold Cardium Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Nomura Holdings March 31, 2013 15000 $1950
S.A.C. Capital Advisors June 30, 2010 42200 $15192
RHUMBLINE ADVISERS March 31, 2010 127300 $56012